A Variant of IL1B Is Associated with the Risk and Blood Lipid Levels of Myocardial Infarction in Eastern Chinese Individuals

References

• Abdel Ghafar MT. 2019. Association of aldosterone synthase CYP11B2 (−344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population. Clin Exp Hypertens. 41(8):779–86.
   PubMed Web of Science ®Google Scholar
• Abdel Ghafar MT. 2020. An overview of the classical and tissue-derived renin-angiotensin-aldosterone system and its genetic polymorphisms in essential hypertension. Steroids. 163:108701.
   PubMed Web of Science ®Google Scholar
• Abraham G, Bhalala OG, De Bakker PI, Ripatti S, Inouye M. 2014. Towards a molecular systems model of coronary artery disease. Curr Cardiol Rep. 16(6):488.
   PubMed Web of Science ®Google Scholar
• Acton RT, Go RC, Roseman JM. 2004. Genetics and cardiovascular disease. Ethn Dis. 14(4):S2-8-16.
   Web of Science ®Google Scholar
• Bhaskar V, Yin J, Mirza AM, Phan D, Vanegas S, Issafras H, Michelson K, Hunter JJ, Kantak SS. 2011. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Atherosclerosis. 216(2):313–20.
   PubMed Web of Science ®Google Scholar
• Braunwald E. 1997. Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 337(19):1360–69.
   PubMed Web of Science ®Google Scholar
• Buja LM, Willerson JT. 1994. Role of inflammation in coronary plaque disruption. Circulation. 89(1):503–05.
   PubMed Web of Science ®Google Scholar
• Chamberlain J, Francis S, Brookes Z, Shaw G, Graham D, Alp NJ, Dower S, Crossman DC. 2009. Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS One. 4(4):e5073.
   PubMed Web of Science ®Google Scholar
• Chen B, Geng J, Gao SX, Yue WW, Liu Q. 2018. Eplerenone modulates interleukin-33/sST2 signaling and IL-1beta in left ventricular systolic dysfunction after acute myocardial infarction. J Interferon Cytokine Res. 38(3):137–44.
   PubMed Web of Science ®Google Scholar
• Coker A, Arman A, Soylu O, Tezel T, Yildirim A. 2011. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet. 38(3):201–08.
   PubMed Web of Science ®Google Scholar
• Daraei A, Mansoori Y, Zendebad Z, Tavakkoly-Bazzaz J, Madadizadeh F, Naghizadeh MM, Arghavani A, Mansoori B. 2017. Influences of IL-1b-3953 C>T and MMP-9-1562C >T gene variants on myocardial infarction susceptibility in a subset of the Iranian population. Genet Test Mol Biomarkers. 21(1):33–38.
   PubMed Web of Science ®Google Scholar
• De Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G. 2017. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 40(9):1273–84.
   PubMed Web of Science ®Google Scholar
• Deten A, Volz HC, Briest W, Zimmer HG. 2002. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res. 55(2):329–40.
   PubMed Web of Science ®Google Scholar
• Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature. 487(7407):325–29. doi:https://doi.org/10.1038/nature11260.
   PubMed Web of Science ®Google Scholar
• Epingeac ME, Gaman MA, Diaconu CC, Gad M, Am G. 2019. The evaluation of oxidative stress levels in obesity. Rev Chim [Internet]. 70(6):2241–44.
   Web of Science ®Google Scholar
• Fang Y, Xie H, Lin Z. 2018. Association between IL-1beta + 3954C/T polymorphism and myocardial infarction risk: a meta-analysis. Medicine (Baltimore). 97(30):e11645.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML. 1998. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 30(12):2567–76.
   PubMed Web of Science ®Google Scholar
• Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. 1996. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 16(8):1000–06.
   PubMed Web of Science ®Google Scholar
• Gaman AM, Moisa C, Diaconu CC, Ma G. 2019. Crosstalk between oxidative stress, chronic inflammation and disease progression in essential thrombocythemia. Rev Chim [Internet]. 70(10):3486–89.
   Web of Science ®Google Scholar
• Gaman MA, Cozma MA, Dobrica EC, Bacalbasa N, Bratu OG, Diaconu CC. 2020a. Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes. Metabolites. 10(5):195.
   Web of Science ®Google Scholar
• Gaman MA, Epingeac ME, Diaconu CC, Gaman AM. 2020b. Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters. World J Diabetes. 11(5):193–201.
   PubMed Web of Science ®Google Scholar
• Ghafar MTA. 2019. Aldosterone synthase gene (CYP11B2) polymorphisms and enhanced cardiovascular risk. In: The recent topics in genetic polymorphisms. Mahmut Çalışkan, Osman Erol and Gül Cevahir Öz, IntechOpen. doi:https://doi.org/10.5772/intechopen.89133.
   Google Scholar
• Juan Z, Wei-Guo Z, Heng-Liang S, Da-Guo W. 2015. Association of matrix metalloproteinase 9 C-1562T polymorphism with genetic susceptibility to myocardial infarction: a meta-analysis. Curr Ther Res Clin Exp. 77:40–45.
   PubMed Web of Science ®Google Scholar
• Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. 2003. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 23(4):656–60.
   PubMed Web of Science ®Google Scholar
• Latella MC, De Gaetano M, Di Castelnuovo A, Napoleone E, Lorenzet R, Gattone M, Giannuzzi P, Rogus J, Huttner K, Donati MB, et al. 2009. Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells. Immunol Invest. 38(3–4):203–19.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jung YH, Song EJ, Jang KK, Choi SH, Han HJ. 2015. Vibrio vulnificus VvpE stimulates IL-1beta production by the hypomethylation of the IL-1beta promoter and NF-kappaB activation via lipid raft-dependent ANXA2 recruitment and reactive oxygen species signaling in intestinal epithelial cells. J Immunol. 195(5):2282–93.
   PubMed Web of Science ®Google Scholar
• Libby P. 2002. Inflammation in atherosclerosis. Nature. 420(6917):868–74.
   PubMed Web of Science ®Google Scholar
• Moisa C, Gaman MA, Diaconu CC, Am G. 2019. Oxidative stress levels, JAK2V617F mutational status and thrombotic complications in patients with essential thrombocythemia. Rev Chim [Internet]. 70(8):2822–25.
   Web of Science ®Google Scholar
• Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. 1980. Genetic–epidemiologic study of early-onset ischemic heart disease. Circulation. 61(3):503–08.
   PubMed Web of Science ®Google Scholar
• Oliveira GB, Avezum A, Roever L. 2015. Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention. Front Cardiovasc Med. 2:32.
   PubMedGoogle Scholar
• Olofsson PS, Sheikine Y, Jatta K, Ghaderi M, Samnegard A, Eriksson P, Sirsjo A. 2009. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta: interleukin-1receptor antagonist balance in atherosclerosis. Circ J. 73(8):1531–36.
   PubMed Web of Science ®Google Scholar
• Roberts R, Stewart AF. 2012. Genes and coronary artery disease: where are we? J Am Coll Cardiol. 60(18):1715–21.
   PubMed Web of Science ®Google Scholar
• Sakowicz A, Fendler W, Lelonek M, Pietrucha T. 2010. Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. Arch Med Sci. 6(2):160–67.
   PubMed Web of Science ®Google Scholar
• Stein JM, Smeets R, Reichert S, Chrobot J, Fickl S, Stanzel S, Kuch B. 2009. The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction. J Periodontol. 80(7):1095–102.
   PubMed Web of Science ®Google Scholar
• Wang S, Dai YX, Chen LL, Jiang T, Zheng MQ, Li CG, Chen YP, Lin WH, Zhang JF, Jiang J. 2015. Effect of IL-1beta, IL-8, and IL-10 polymorphisms on the development of myocardial infarction. Genet Mol Res. 14(4):12016–21.
   PubMed Web of Science ®Google Scholar
• White HD, Chew DP. 2008. Acute myocardial infarction. Lancet. 372(9638):570–84.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M. 2002. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 347(24):1916–23.
   PubMed Web of Science ®Google Scholar
• Yang TC, Chang PY, Lu SC. 2017. L5-LDL from ST-elevation myocardial infarction patients induces IL-1beta production via LOX-1 and NLRP3 inflammasome activation in macrophages. Am J Physiol Heart Circ Physiol. 312(2):H265–H274.
   PubMed Web of Science ®Google Scholar
• Yucesoy B, Kurzius-Spencer M, Johnson VJ, Fluharty K, Kashon ML, Guerra S, Luster MI, Burgess JL. 2008. Association of cytokine gene polymorphisms with rate of decline in lung function. J Occup Environ Med. 50(6):642–48.
   PubMed Web of Science ®Google Scholar
• Zee RY, Hennessey H, Michaud SE, Ridker PM. 2008. Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis. 201(1):124–29.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Du S, Shen S, Wang L. 2020. microRNA-132 inhibits cardiomyocyte apoptosis and myocardial remodeling in myocardial infarction by targeting IL-1beta. J Cell Physiol. 235(3):2710–21.
   PubMed Web of Science ®Google Scholar